These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 14670837
1. Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Harja E, Bucciarelli LG, Lu Y, Stern DM, Zou YS, Schmidt AM, Yan SF. Circ Res; 2004 Feb 20; 94(3):333-9. PubMed ID: 14670837 [Abstract] [Full Text] [Related]
2. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Ohta H, Wada H, Niwa T, Kirii H, Iwamoto N, Fujii H, Saito K, Sekikawa K, Seishima M. Atherosclerosis; 2005 May 20; 180(1):11-7. PubMed ID: 15823270 [Abstract] [Full Text] [Related]
3. Interleukin-10 suppresses tissue factor expression in lipopolysaccharide-stimulated macrophages via inhibition of Egr-1 and a serum response element/MEK-ERK1/2 pathway. Kamimura M, Viedt C, Dalpke A, Rosenfeld ME, Mackman N, Cohen DM, Blessing E, Preusch M, Weber CM, Kreuzer J, Katus HA, Bea F. Circ Res; 2005 Aug 19; 97(4):305-13. PubMed ID: 16037570 [Abstract] [Full Text] [Related]
4. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M. Arterioscler Thromb Vasc Biol; 2003 Apr 01; 23(4):656-60. PubMed ID: 12615675 [Abstract] [Full Text] [Related]
5. Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, Burns WC, Twigg SM, Dilley RJ, Cooper ME, Allen TJ. Circulation; 2002 Jul 09; 106(2):246-53. PubMed ID: 12105166 [Abstract] [Full Text] [Related]
7. Enzymatically degraded low density lipoproteins are more potent inducers of egr-1 mRNA than oxidized or native low density lipoproteins. Stoyanova E, Tesch A, Armstrong VW, Wieland E. Clin Biochem; 2001 Sep 09; 34(6):483-90. PubMed ID: 11676978 [Abstract] [Full Text] [Related]
8. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model. Albrecht C, Preusch MR, Hofmann G, Morris-Rosenfeld S, Blessing E, Rosenfeld ME, Katus HA, Bea F. Cardiovasc Res; 2010 May 01; 86(2):321-9. PubMed ID: 20110335 [Abstract] [Full Text] [Related]
9. Oxidized phospholipids trigger atherogenic inflammation in murine arteries. Furnkranz A, Schober A, Bochkov VN, Bashtrykov P, Kronke G, Kadl A, Binder BR, Weber C, Leitinger N. Arterioscler Thromb Vasc Biol; 2005 Mar 01; 25(3):633-8. PubMed ID: 15591214 [Abstract] [Full Text] [Related]
10. Functional inhibition of Ras by S-trans,trans-farnesyl thiosalicylic acid attenuates atherosclerosis in apolipoprotein E knockout mice. George J, Afek A, Keren P, Herz I, Goldberg I, Haklai R, Kloog Y, Keren G. Circulation; 2002 May 21; 105(20):2416-22. PubMed ID: 12021230 [Abstract] [Full Text] [Related]
11. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice. Nachtigal P, Pospisilova N, Jamborova G, Pospechova K, Solichova D, Andrys C, Zdansky P, Micuda S, Semecky V. Life Sci; 2008 Mar 26; 82(13-14):708-17. PubMed ID: 18289605 [Abstract] [Full Text] [Related]
12. Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis. Borst O, Schaub M, Walker B, Schmid E, Münzer P, Voelkl J, Alesutan I, Rodríguez JM, Vogel S, Schoenberger T, Metzger K, Rath D, Umbach A, Kuhl D, Müller II, Seizer P, Geisler T, Gawaz M, Lang F. Arterioscler Thromb Vasc Biol; 2015 Mar 26; 35(3):547-57. PubMed ID: 25614279 [Abstract] [Full Text] [Related]
13. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC, Luthringer D, Xu XP, Rajavashisth TB, Yano J, Kaul S, Arditi M. Circulation; 2001 Dec 18; 104(25):3103-8. PubMed ID: 11748108 [Abstract] [Full Text] [Related]
17. Extinguishing Egr-1-dependent inflammatory and thrombotic cascades after lung transplantation. Okada M, Fujita T, Sakaguchi T, Olson KE, Collins T, Stern DM, Yan SF, Pinsky DJ. FASEB J; 2001 Dec 18; 15(14):2757-9. PubMed ID: 11606484 [Abstract] [Full Text] [Related]
18. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background. Sontag TJ, Krishack PA, Lukens JR, Bhanvadia CV, Getz GS, Reardon CA. Arterioscler Thromb Vasc Biol; 2014 Feb 18; 34(2):262-9. PubMed ID: 24334873 [Abstract] [Full Text] [Related]
19. Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway. Bea F, Puolakkainen MH, McMillen T, Hudson FN, Mackman N, Kuo CC, Campbell LA, Rosenfeld ME. Circ Res; 2003 Mar 07; 92(4):394-401. PubMed ID: 12600889 [Abstract] [Full Text] [Related]
20. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. McCaffrey TA, Fu C, Du B, Eksinar S, Kent KC, Bush H, Kreiger K, Rosengart T, Cybulsky MI, Silverman ES, Collins T. J Clin Invest; 2000 Mar 07; 105(5):653-62. PubMed ID: 10712437 [Abstract] [Full Text] [Related] Page: [Next] [New Search]